SPECIAL BULLETIN COVID-19 #208-209 Now Available

The NC Division of Health Benefits (DHB) has recently published new Medicaid Bulletin articles pertaining to COVID-19:

SPECIAL BULLETIN COVID-19 #208: Amended Outpatient Billing Guidance for Vaccine and Monoclonal Antibody Administration

To allow claims to process at CMS approved rates, providers should bill with Revenue Code 0771 instead of Revenue Code 0261 on future claims for the vaccine and monoclonal antibody administration services noted here.

SPECIAL BULLETIN COVID-19 #209: HCPCS Code Q0220: Billing Guidelines for Tixagevimab and Cilgavimab, Copackaged as Evusheld

Effective with date of service Dec. 8, 2021, the NC Medicaid and NC Health Choice programs cover tixagevimab injection; cilgavimab injection, copackaged for intramuscular use (Evusheld™) for use in the Physician Administered Drug Program (PADP). Criteria and billing information

Providers are encouraged to review this information. All bulletin articles, including those related to COVID-19, are available on DHB's Medicaid Bulletin webpage.